Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients
Clinical trial NCT05901987 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05901987
- Sponsor
- GeneCradle Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2025-04-22
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.